Key result
Plasma NOx concentrations do not reliably reflect nitric oxide formation in vivo, suggesting that high-molecular weight nitrosothiols like nitrosoalbumin may serve as alternative markers.
Plasma NOx is an unreliable marker of in vivo nitric oxide formation due to confounding by elimination rates and contamination, highlighting the need for alternative markers like nitrosoalbumin.
Answers are grounded in this paper and cite their sources.
Plasma NOx should not guide clinical nitric oxide assessment; leaves open validation of nitrosoalbumin as alternative marker.
Although plasma NOx (NO(2)(-) and NO(3)(-)) has been used as an index of nitric oxide (NO) formation in vivo, many unreasonable results appeared even after active elimination of NOx contamination from laboratory ware. For example, plasma NOx concentrations did not increase during vasodilation mediated by the NO/cGMP pathway or after organ perfusion. A possible shift of NOx from plasma to erythrocytes (RBCs) as a cause of these phenomena has been excluded, leaving the destination of NOx (after leaving plasma) unknown. Kinetic analyses have revealed that steady state NOx concentrations in plasma and whole blood did not correlate with the NOx formation rate, but rather with the NOx elimination rate. Therefore, the supposition that the NO status is directly reflected by plasma NOx concentrations appears untenable. As nitrosothiols (R-SNOs), possible carriers of NO bioactivity, have been flagged as alternative indices of NO status in vivo, efforts have been made to detect these substances. When interference by ultrafiltration was eliminated, low molecular weight R-SNOs such as nitrosocystein and nitrosogluthathione were undetectable. However, a high-molecular weight R-SNO, nitrosoalbumin, was detected in human blood. Further research is required into the significance and practical use of nitrosoalbumin as a marker of NO in vivo.
No takes yet. Share an insight, caveat, or question.
Ishibashi et al. (2003) conducted a review in Endothelial dysfunction. Plasma NOx concentrations do not reliably reflect nitric oxide formation in vivo, suggesting that high-molecular weight nitrosothiols like nitrosoalbumin may serve as alternative markers.
Synapse has enriched 10 related papers. Consider them for comparative context: